Acta Medica Scandinavica 1984-01-01

Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.

M Boberg, A Killander

Index: Acta Med. Scand. 215(3) , 221-4, (1984)

Full Text: HTML

Abstract

Eleven patients with recurrent venous thrombosis or thrombophlebitis and a decreased fibrinolytic activity after venous occlusion were given a phenformin-like substance, moroxydine chloride, for 6 months. No sustained increase in the fibrinolytic activity was observed after moroxydine treatment.

Related Compounds

Related Articles:

[The efficacy of a combined therapy against herpes virus genital infections].

1992-01-01

[Rev. Roum. Virol. 43(3-4) , 201-6, (1992)]

Immunologic and antiviral therapy in herpetic keratitis.

1992-01-01

[Roum. Arch. Microbiol. Immunol. 51(4) , 233-7, (1992)]

Synthesis and molecular mechanical studies of antiviral copper(II) complexes with morpholinebiguanide drug.

1998-01-01

[Roum. Arch. Microbiol. Immunol. 57(3-4) , 279-93, (1998)]

Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.

1982-01-01

[J. Med. 13(5-6) , 353-64, (1982)]

Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity.

1995-03-01

[Thromb. Haemost. 73(3) , 362-7, (1995)]

More Articles...